Fidelity Investments
BIOA

Fidelity Investments’s BioAge Labs BIOA Stock Holding History

Fidelity Investments’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Buy
190,298
+72,595
+62% +$1.4M ﹤0.01% 2445
2025
Q4 		$1.56M Buy
117,703
+26,585
+29% +$236K ﹤0.01% 2693
2025
Q3 		$536K Buy
91,118
+13,563
+17% +$63.5K ﹤0.01% 3005
2025
Q2 		$320K Buy
77,555
+5,248
+7% +$21.1K ﹤0.01% 3134
2025
Q1 		$272K Buy
72,307
+72,300
+1,032,857% +$334K ﹤0.01% 3134
2024
Q4 		$41 Buy
+7
New +$121 ﹤0.01% 5223

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Fidelity Investments's BIOA Position: Q1 2026 in Review

Fidelity Investments increased its BioAge Labs (BIOA) stake by 62% in Q1 2026, buying an estimated $1.4M and bringing the position to 190,298 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

Fidelity Investments first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Fidelity Investments held 190,298 shares of BioAge Labs worth $3.33M as of Q1 2026.
  • Fidelity Investments bought 72,595 BioAge Labs shares in Q1 2026, an estimated $1.4M.
  • BioAge Labs made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2445 holding.
  • Fidelity Investments first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.